Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Proportion measure

Year CMS eCQM ID Measure Name
2023 CMS129v12 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2024 CMS129v13 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2025 CMS129v14 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2022 CMS130v10 Colorectal Cancer Screening
2023 CMS130v11 Colorectal Cancer Screening
2024 CMS130v12 Colorectal Cancer Screening
2025 CMS130v13 Colorectal Cancer Screening
2022 CMS131v10 Diabetes: Eye Exam
2023 CMS131v11 Diabetes: Eye Exam
2024 CMS131v12 Diabetes: Eye Exam
2025 CMS131v13 Diabetes: Eye Exam
2022 CMS133v10 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2023 CMS133v11 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2024 CMS133v12 Cataracts: 20 over 40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2025 CMS133v13 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2022 CMS134v10 Diabetes: Medical Attention for Nephropathy
2022 CMS135v10 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 CMS135v11 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 CMS135v12 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 CMS135v13 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

We want your feedback

Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.